fbpx

molecules of the month

DS96432529

oral CDK8 kinase inhibitor

effective in ovariectomized rat model

CDK8 identified as MoA after screen

Bioorganic & Medicinal Chemistry Letters

Daiichi Sankyo Co. Ltd.

Chemical structure of molecule DS96432529 Daiichi Sankyo CDK8 kinase inhibitor
1 min read

7.     The Daiichi Sankyo CDK8 kinase inhibitor, DS96432529, is intended to be a bone anabolic agent. The molecule shows preclinical efficacy and synergy with alendronate or parathyroid hormone. The discovery program was initiated well before the likely target (CDK8) was identified and provides an interesting retrospective case study for phenotypic drug discovery.


request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.


already a member? log in: